Camizestrant TFA是一种有效的口服雌激素受体拮抗剂。

Camizestrant TFA is a potent and orally active antagonist of estrogen receptor (ER).

Camizestrant TFA (oral administration; 0.2-50 mg/kg; 20 days) shows anti-tumour efficacy in human parental MCF7 mice xenograft. Camizestrant TFA (oral administration; 0.8-40 mg/kg; 30 days) decreases tumor growth. Camizestrant TFA gives almost complete tumour growth inhibition at the doses >10 mg/kg in mice[1].

T11237L

C26H29F7N6O2

590.54

Camizestrant TFA(2222844-89-3 Free base);AZD-9833 TFA;Camizestrant TFA

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years